Henry (Harv) M. Rinder, MD, FASCP, was installed today as 2021-2022 President of the American Society for Clinical Pathology (ASCP) during the Society’s Annual Meeting held Oct. 27-29, in Boston.
Dr. Rinder is active in research on inflammation, platelets, and hemostasis; he consults in hematology, teaches residents and fellows in pathology and hematology, and directs the hematology laboratory at Yale-New Haven Hospital. He has been an attending physician at Yale-New Haven Hospital since 1992.
“I am truly honored to have been elected as an officer of ASCP, a society that represents the entire pathology and medical laboratory team and impacts health care around the globe,” he said.
Dr. Rinder has been an active volunteer for ASCP, serving as a Fellow at-Large on the Board of Directors, as chair of the Commission on Continuing Professional Development, as chair of the Resident In-Service Examination committee, as a member of the Training Residents in Genomics (TRIG) Committee, and on other committees tasked with education, professional development, and serving the pathology and laboratory professional workforce.
Dr. Rinder earned a bachelor’s degree from Yale College, New Haven, CT, and a medical degree from the University of Vermont, Burlington, VT. At UVM, Dr. Rinder completed a post-sophomore pathology fellowship under Drs. John Craighead, chair of the Department of Pathology and a seminal investigator of pulmonary asbestosis, Jack Clemmons, a pioneer in anticoagulants and one of the first African Americans to join UVM’s College of Medicine, and Wash Winn, a trailblazer in infectious disease and Legionella pathology. Dr. Rinder trained in internal medicine at Maine Medical Center under Drs. Robert Hillman, the discoverer of iron homeostasis, and Ken Ault, an innovator of hematology diagnostics, then returned to Yale School of Medicine for training in clinical hematology and clinical pathology, coming on staff at Yale New Haven Hospital in 1992.
